The Rechallenge of ADCs in MBC Patients

Fudan University

Status: Active, not recruiting

Conditions: Breast Cancer

Treatments: Drug: ADC

Study type: Observational

Funder types: Other

Identifiers

NCT05571618

YOUNGBC-23

Details and patient eligibility

About

To investigate the efficacy and safety of ADC rechallenge

Enrollment: 100 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age > 18 years old.
• Diagnosed with Metastatic Breast Cancer.
• Patients with prior exposure to ADC (either in the adjuvant setting or metastatic disease are allowed).
• Patients plan to or have received ADCs for the second or more time.
• Complete medical history was available.

Exclusion criteria

• Medical history was incomplete

Trial design

100 participants in 1 patient group

Group1

Treatment:

Drug: ADC